Portfolio and technology meetings

Pharmaceutical companies with large portfolios can attend free, virtual meetings with European Medicines Agency (EMA). These meetings address development issues and anticipate future scientific and regulatory needs. They aim to support successful product portfolio development.

Pharmaceutical companies with large medicinal product portfolios can apply to attend informal meetings with EMA.

These meetings can:

• identify any issues impacting the progress of product portfolios and assist successful development;
• capture innovative and disruptive technologies;
• anticipate the scientific and regulatory expertise needed to assess future applications.

They are free-of-charge and held virtually.

How to apply

EMA publishes two calls for applications each year.

The first call, which EMA publishes in September, invites applications for meetings scheduled in the first half of the following year.

The second call, which EMA publishes in March, invites applications for meetings held in the second half of the year.

You can find an overview of the application timeline below:

1. Step 1

   The applicant completes the application form. EMA reviews the applications received and confirms the meeting.

2. Step 2

   If the meeting is granted, EMA asks the applicant to complete and send a briefing document 4 to 6 weeks before the scheduled meeting.

Portfolio and technology meeting briefing document

Reference Number: EMA/571070/2023

Portfolio and technology meeting report

Reference Number: EMA/247780/2023

Instructions on how to apply for a portfolio & technology meeting (PTM)